Disease | Men | Women | Total | ||||||
---|---|---|---|---|---|---|---|---|---|
(Year 2010) | Age at semi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | Age at semi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | Age atsemi-maximum (prevalence at semi-maximum, R2) | Age shift (years) | |||
Without T2DM. | With T2DM | Â | Without T2DM | With T2DM | Â | Without T2DM | With T2DM | Â | |
Adiposity | 38.0 (5.07, 0.95) | 24.7 (16.97, 0.99) | 13 | 31.8 (7.88, 0.96) | <20* (24.50, 1.00) | NC | 34.3 (6.59, 0.96) | 21.9 (20.56, 0.99) | 12 |
Hypertension | 56.5 (34.74, 0.97) | 37.7 (42.39, 0.98) | 19 | 60.8 (37.58, 0.97) | 40.9 (44.21, 0.97) | 20 | 60.5 (36.56, 0.97) | 40.3 (43.54, 0.98) | 20 |
Coronary heart disease | 69.7 (16.74, 0.99) | 61.5 (21.51, 0.98) | 8 | 72.8 (12.38, 0.97) | 68.9 (16.53, 1.00) | 4 | 70.5 (13.42, 0.99) | 62.5 (17.64, 0.98) | 8 |
Stroke | 71.1 (3.05, 0.97) | 67.6 (4.45, 0.98) | 5 | 74.2 (2.45, 0.94) | 70.2 (3.45, 0.99) | 4 | 72.2 (2.59, 0.97) | 67.8 (3.66, 0.99) | 4 |
Renal insufficiency | 73.0 (6.97, 0.96) | 66.1 (8.13, 0.97) | 7 | 74.4 (4.54, 0.93) | 66.0 (5.64, 0.98) | 8 | 72.7 (5.12, 0.96) | 64.0 (6.19, 0.99) | 9 |
Retinopathy | 70.3 (9.53, 0.98) | 45.7 (15.60, 0.95) | 25 | 69.0 (10.32, 0.96) | 48.9 (16.39, 0.92) | 20 | 69.1 (9.79, 0.97) | 47.9 (16.07, 0.94) | 21 |